NEWS
2023.05.25
Release
Less than 10% of the respondents used ChatGPT and other generative AIs on a daily basis; More than 90% of the finance and insurance industry has used the system, while 30% of the manufacturing industry has not used it. ―ExaWizards conducted a questionnaire survey on the use of a generative AI to participants of its seminar supported by the Japan Business Federation to which 514 people from 274 companies responded―
2023.05.22
Release
SocioFuture Adopts “exaBase DX Assessment & Learning” Approx. 500 employees playing leading roles in operational reforms have started to receive e-learning training
―With ExaWizards’ support, SocioFuture identifies employees’ skills and abilities aiming to build an organizational structure where each department can voluntarily promote operational reforms utilizing DX by FY2025―
2023.05.15
Release
ExaWizards, ChatGPT Service for Enterprises “exaBase Generative AI powered by GPT-4″ Service Launched ~Security and compliance management included as standard features, 900 yen/month basic fee, accepting applications for a free trial~
2023.05.11
Release
ExaWizards and SANKEN, Osaka University Jointly Operationalizes Program Medical Device (SaMD) for Major Neurocognitive Disorder Diagnosis Support
-Basic agreement reached on exclusive development and marketing of AI applications based on patents for medical evaluation-
2023.05.10
Release
“exaBase DX Assessment & Learning” : Releasing “DIA 3.0” Assessment Fully Compliant with Ministry of Economy, Trade and Industry’s “Digital Skill Standards” This Summer
“All-encompassing DX Talent Search and Training: Supporting Two Standards, DX Literacy Standards and DX Promotion Skill Standards”
2023.05.10
Release
ExaWizards Starts Accepting Reservations for a Beta Version of “exaBase IR Assistant powered by ChatGPT”
—ChatGPT-enabled efficient IR support, generating assumed questions and answers optimized for each company. Patent pending for the generative process visualization technology that realizes accuracy improvement by the user.
2023.05.08
Release
ExaWizards and Kyoto University Develop Drug Safety Evaluation AI Learning from PMDA Evaluation Results 〜Promote more efficient reporting and evaluation of pharmaceutical products and reduce the number of cases requiring human evaluation〜
2023.04.27
Release
ExaWizards Acquires a Patent for Anomaly Detection Technology Combining AI and Optics -AI that detects foreign matter contamination or state changes not detectable with the human eye by recognizing the test object and optimizes the wavelengths of lights applied to it-
2023.04.26
Release
Exawizards Has Begun Accepting Applications for Its New “exaBase Generative AI built with GPT-4” Service for Companies Interested in using ChatGPT ~￥900/Month Basic Fee, Security and Compliance Management Features Come Standard ~
2023.04.24
Release